Epsilon M&A Deal Report - Neo Apotek
Transaction Multiples for the Valuation of Private Companies
Dr. Max Group / Neo Apotek
No EMAT :
121679
Announced Date :
17/11/2023
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Dr. Max Group
Target :
Neo Apotek
Country :
Italy
Sector of activity :
- Pharmaceuticals & Cosmetics R&W > Retail and Wholesale ('R&W') > Drugs Retailers
Business Description :
Neo Apotek is an Italian pharmacy retail chain operating approximately 130 pharmacies across northern and central Italy. The group provides pharmaceutical products and services through modern,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Drugs Retailers » = 59
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/03/2024 | Manutan International | Findel Education | United Kingdom | ** | 121658 |
| 28/06/2021 | Farmaè (Talea Group) | Amicafarmacia | Italy | *** | 121653 |
Source: Epsilon Research / EMAT
